Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with <i>RAS</i> mutant solid tumors
PaperCitations, authors & open-access status
Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with <i>RAS</i> mutant solid tumors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2017 year and closed oa status.
10
Citations
2017
Year
closed
OA Status